155 related articles for article (PubMed ID: 29335631)
1. Impact of HLA allele mismatch at HLA-A, -B, -C, -DRB1, and -DQB1 on outcomes in haploidentical stem cell transplantation.
Huo MR; Pei XY; Li D; Chang YJ; Xu LP; Zhang XH; Liu KY; Huang XJ
Bone Marrow Transplant; 2018 May; 53(5):600-608. PubMed ID: 29335631
[TBL] [Abstract][Full Text] [Related]
2. HLA-C antigen mismatch is associated with worse outcome in unrelated donor peripheral blood stem cell transplantation.
Woolfrey A; Klein JP; Haagenson M; Spellman S; Petersdorf E; Oudshoorn M; Gajewski J; Hale GA; Horan J; Battiwalla M; Marino SR; Setterholm M; Ringden O; Hurley C; Flomenberg N; Anasetti C; Fernandez-Vina M; Lee SJ
Biol Blood Marrow Transplant; 2011 Jun; 17(6):885-92. PubMed ID: 20870028
[TBL] [Abstract][Full Text] [Related]
3. High-resolution HLA matching in hematopoietic stem cell transplantation: a retrospective collaborative analysis.
Fürst D; Müller C; Vucinic V; Bunjes D; Herr W; Gramatzki M; Schwerdtfeger R; Arnold R; Einsele H; Wulf G; Pfreundschuh M; Glass B; Schrezenmeier H; Schwarz K; Mytilineos J
Blood; 2013 Oct; 122(18):3220-9. PubMed ID: 24046013
[TBL] [Abstract][Full Text] [Related]
4. Outcome of haematopoietic stem cell transplantation in patients transplanted with matched unrelated donors vs allele-mismatched donors: a single centre study.
Hauzenberger D; Schaffer M; Ringdén O; Hassan Z; Omazic B; Mattsson J; Wikström AC; Remberger M
Tissue Antigens; 2008 Dec; 72(6):549-58. PubMed ID: 19000143
[TBL] [Abstract][Full Text] [Related]
5. The clinical significance of human leukocyte antigen (HLA) allele compatibility in patients receiving a marrow transplant from serologically HLA-A, HLA-B, and HLA-DR matched unrelated donors.
Morishima Y; Sasazuki T; Inoko H; Juji T; Akaza T; Yamamoto K; Ishikawa Y; Kato S; Sao H; Sakamaki H; Kawa K; Hamajima N; Asano S; Kodera Y
Blood; 2002 Jun; 99(11):4200-6. PubMed ID: 12010826
[TBL] [Abstract][Full Text] [Related]
6. Biological significance of HLA locus matching in unrelated donor bone marrow transplantation.
Morishima Y; Kashiwase K; Matsuo K; Azuma F; Morishima S; Onizuka M; Yabe T; Murata M; Doki N; Eto T; Mori T; Miyamura K; Sao H; Ichinohe T; Saji H; Kato S; Atsuta Y; Kawa K; Kodera Y; Sasazuki T;
Blood; 2015 Feb; 125(7):1189-97. PubMed ID: 25519752
[TBL] [Abstract][Full Text] [Related]
7. Pretransplant active disease status and HLA class II mismatching are associated with increased incidence and severity of cytokine release syndrome after haploidentical transplantation with posttransplant cyclophosphamide.
Mariotti J; Taurino D; Marino F; Bramanti S; Sarina B; Morabito L; De Philippis C; Di Vito C; Mavilio D; Carlo-Stella C; Della Porta M; Santoro A; Castagna L
Cancer Med; 2020 Jan; 9(1):52-61. PubMed ID: 31702882
[TBL] [Abstract][Full Text] [Related]
8. Which donor should be chosen for hematopoietic stem cell transplantation among unrelated HLA-A, -B, and -DRB1 genomically identical volunteers?
Ringdén O; Schaffer M; Le Blanc K; Persson U; Hauzenberger D; Abedi MR; Olerup O; Ljungman P; Remberger M
Biol Blood Marrow Transplant; 2004 Feb; 10(2):128-34. PubMed ID: 14750078
[TBL] [Abstract][Full Text] [Related]
9. [The impact of HLA high resolution typing mismatching of donor-recipient pairs on outcome of unrelated donor hematopoietic stem cell transplantation].
He J; Xu C; Wu XJ; Bao XJ; Qiu QC; Yuan XN; Li Y; Shen HJ; Wu DP; Hong JL; Liu JH; DU HY; Zhang L; DU D; Lu J; Liu J
Zhonghua Xue Ye Xue Za Zhi; 2012 May; 33(5):353-7. PubMed ID: 22781790
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of HistoCheck as a Predictor of Clinical Outcomes after Haploidentical Hematopoietic Stem Cell Transplantation.
Huo MR; Li D; Chang YJ; Xu LP; Zhang XH; Liu KY; Huang XJ
Biol Blood Marrow Transplant; 2018 Sep; 24(9):1866-1872. PubMed ID: 29751115
[TBL] [Abstract][Full Text] [Related]
11. Related transplantation with HLA-1 Ag mismatch in the GVH direction and HLA-8/8 allele-matched unrelated transplantation: a nationwide retrospective study.
Kanda J; Saji H; Fukuda T; Kobayashi T; Miyamura K; Eto T; Kurokawa M; Kanamori H; Mori T; Hidaka M; Iwato K; Yoshida T; Sakamaki H; Tanaka J; Kawa K; Morishima Y; Suzuki R; Atsuta Y; Kanda Y
Blood; 2012 Mar; 119(10):2409-16. PubMed ID: 22042692
[TBL] [Abstract][Full Text] [Related]
12. HLA-inferred extended haplotype disparity level is more relevant than the level of HLA mismatch alone for the patients survival and GvHD in T cell-replate hematopoietic stem cell transplantation from unrelated donor.
Nowak J; Nestorowicz K; Graczyk-Pol E; Mika-Witkowska R; Rogatko-Koros M; Jaskula E; Koscinska K; Madej S; Tomaszewska A; Nasilowska-Adamska B; Szczepinski A; Halaburda K; Dybko J; Kuliczkowski K; Czerw T; Giebel S; Holowiecki J; Baranska M; Pieczonka A; Wachowiak J; Czyz A; Gil L; Lojko-Dankowska A; Komarnicki M; Bieniaszewska M; Kucharska A; Hellmann A; Gronkowska A; Jedrzejczak WW; Markiewicz M; Koclega A; Kyrcz-Krzemien S; Mielcarek M; Kalwak K; Styczynski J; Wysocki M; Drabko K; Wojcik B; Kowalczyk J; Gozdzik J; Pawliczak D; Gwozdowicz S; Dziopa J; Szlendak U; Witkowska A; Zubala M; Gawron A; Warzocha K; Lange A
Hum Immunol; 2018 Jun; 79(6):403-412. PubMed ID: 29605688
[TBL] [Abstract][Full Text] [Related]
13. HLA informs risk predictions after haploidentical stem cell transplantation with posttransplantation cyclophosphamide.
Fuchs EJ; McCurdy SR; Solomon SR; Wang T; Herr MR; Modi D; Grunwald MR; Nishihori T; Kuxhausen M; Fingerson S; McKallor C; Bashey A; Kasamon YL; Bolon YT; Saad A; McGuirk J; Paczesny S; Gadalla SM; Marsh SGE; Shaw BE; Spellman SR; Lee SJ; Petersdorf EW
Blood; 2022 Mar; 139(10):1452-1468. PubMed ID: 34724567
[TBL] [Abstract][Full Text] [Related]
14. Impact of HLA Disparity in Haploidentical Bone Marrow Transplantation Followed by High-Dose Cyclophosphamide.
Raiola AM; Risitano A; Sacchi N; Giannoni L; Signori A; Aquino S; Bregante S; Di Grazia C; Dominietto A; Geroldi S; Ghiso A; Gualandi F; Lamparelli T; Tedone E; Van Lint MT; Varaldo R; Ibatici A; Marani C; Marotta S; Guolo F; Avenoso D; Garbarino L; Pane F; Bacigalupo A; Angelucci E
Biol Blood Marrow Transplant; 2018 Jan; 24(1):119-126. PubMed ID: 29024804
[TBL] [Abstract][Full Text] [Related]
15. Impact of Human Leukocyte Antigen Allele Mismatch in Unrelated Bone Marrow Transplantation with Reduced-Intensity Conditioning Regimen.
Yokoyama H; Kanda J; Fuji S; Kim SW; Fukuda T; Najima Y; Ohno H; Uchida N; Ueda Y; Eto T; Iwato K; Kobayashi H; Ozawa Y; Kondo T; Ichinohe T; Atsuta Y; Kanda Y;
Biol Blood Marrow Transplant; 2017 Feb; 23(2):300-309. PubMed ID: 27845190
[TBL] [Abstract][Full Text] [Related]
16. Early Fever after Haploidentical Bone Marrow Transplantation Correlates with Class II HLA-Mismatching and Myeloablation but Not Outcomes.
McCurdy SR; Muth ST; Tsai HL; Symons HJ; Huff CA; Matsui WH; Borrello I; Gladstone DE; Swinnen LJ; Cooke KR; Brodsky RA; Bolaños-Meade J; Ambinder RF; Varadhan R; Luznik L; Jones RJ; Bettinot MP; Fuchs EJ
Biol Blood Marrow Transplant; 2018 Oct; 24(10):2056-2064. PubMed ID: 29909152
[TBL] [Abstract][Full Text] [Related]
17. Definition of HLA-DQ as a transplantation antigen.
Petersdorf EW; Longton GM; Anasetti C; Mickelson EM; Smith AG; Martin PJ; Hansen JA
Proc Natl Acad Sci U S A; 1996 Dec; 93(26):15358-63. PubMed ID: 8986816
[TBL] [Abstract][Full Text] [Related]
18. Comparison of efficacy between HLA6/6- and HLA3/6-matched haploidentical hematopoietic stem cell transplant in T-cell-replete transplants between parents and children.
Yu W; Wang Y; Wu D; Liu Q; Xu L; Zhang X; Liu K; Huang X
Sci China Life Sci; 2019 Jan; 62(1):104-111. PubMed ID: 29869037
[TBL] [Abstract][Full Text] [Related]
19. Number of HLA-Mismatched Eplets Is Not Associated with Major Outcomes in Haploidentical Transplantation with Post-Transplantation Cyclophosphamide: A Center for International Blood and Marrow Transplant Research Study.
Zou J; Wang T; He M; Bolon YT; Gadalla SM; Marsh SGE; Kuxhausen M; Gale RP; Sharma A; Assal A; Prestidge T; Aljurf M; Cerny J; Paczesny S; Spellman SR; Lee SJ; Ciurea SO
Transplant Cell Ther; 2022 Feb; 28(2):107.e1-107.e8. PubMed ID: 34774819
[TBL] [Abstract][Full Text] [Related]
20. Tacrolimus does not abrogate the increased risk of acute graft-versus-host disease after unrelated-donor marrow transplantation with allelic mismatching at HLA-DRB1 and HLA-DQB1.
Przepiorka D; Saliba R; Cleary K; Fischer H; Tonai R; Fritsche H; Khouri IF; Folloder J; Ueno NT; Mehra R; Ippoliti C; Giralt S; Gajewski J; Donato M; Claxton D; Braunschweig I; van Besien K; Anderlini P; Andersson BS; Champlin R
Biol Blood Marrow Transplant; 2000; 6(2A):190-7. PubMed ID: 10816027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
